{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-039315","form_type":"8-K/A","ticker":"ADTX","cik":"0001726711","company_name":"Aditxt, Inc.","filed_at":"2024-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.763217+00:00","generated_at":"2026-06-02T23:13:46.176852+00:00","sec_items":["1.02","1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Aditxt reinstates merger with Evofem via Fourth Amendment, pays $1M, extends deadline to July 15","bullets":["Aditxt and Evofem reinstate Merger Agreement via Fourth Amendment dated May 2, 2024, nullifying prior termination notice.","Aditxt makes $1M initial payment; commits to raise up to $2.5M by July 1 for Evofem Series F-1 Preferred Stock.","Termination deadline extended from May 8 to July 15, 2024; 'no shop' clause removed, Evofem may negotiate other deals.","Aditxt must raise $1.5M by June 17 and $1M by July 1, or Evofem can terminate the Merger Agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-039315","json":"https://secwatch.observer/filing/0001213900-24-039315.json","markdown":"https://secwatch.observer/filing/0001213900-24-039315.md","text":"https://secwatch.observer/filing/0001213900-24-039315.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726711/000121390024039315/0001213900-24-039315-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726711/000121390024039315/ea0205208-8ka1_aditxt.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T23:13:46.176852+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8927cd2e6fd5dc4073fcb7ac965edd48e8a5f524","claim":"Aditxt, Inc. terminated Agreement and Plan of Merger with Evofem Biosciences, Inc..","evidence_excerpt":"the Company received notice from Evofem (the “ Termination Notice ”) that Evofem was exercising its right to terminate the Merger Agreement as a result of the Company’s failure to provide the Initial Parent Equity Investment (as defined in the Merger Agreement, as amended)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390024039315/0001213900-24-039315-index.htm","confidence":0.7,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Evofem Biosciences, Inc."}],"fact_type":"material_agreement"},{"claim_id":"cc05e8040ac62df1c19d13c26ee1b791eb913fda","claim":"Aditxt, Inc. amended Reinstatement and Fourth Amendment to the Merger Agreement with Evofem Biosciences, Inc. valued at $1,000,000 (effective 2024-05-02).","evidence_excerpt":"On May 2, 2024, the Company, Adifem, Inc. f/k/a Adicure, Inc. and Evofem Biosciences, Inc. (“Evofem”) entered into the Reinstatement and Fourth Amendment to the Merger Agreement (the “ Fourth Amendment ”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390024039315/0001213900-24-039315-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Evofem Biosciences, Inc."},{"label":"Value","value":"$1,000,000"},{"label":"Effective","value":"2024-05-02"}],"fact_type":"material_agreement"},{"claim_id":"f875de7a93e65779360dbac54a8155a65b6b7acf","claim":"Aditxt, Inc. entered into Agreement and Plan of Merger with Evofem Biosciences, Inc..","evidence_excerpt":"the Company entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Adifem, Inc. f/k/a Adicure, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ Adifem ”) and Evofem Biosciences, Inc., a Delaware corporation (“ Evofem ”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390024039315/0001213900-24-039315-index.htm","confidence":0.7,"family_label":"Material Agreements","details":[{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Evofem Biosciences, Inc."}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}